Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 1;20(11):3429-3435.
doi: 10.31557/APJCP.2019.20.11.3429.

Characterization of High-risk Oncogenic Human Papillomavirus Genotypes in Histologically Confirmed Ear, Nose and Throat (Ent) Cancers in Burkina Faso

Affiliations

Characterization of High-risk Oncogenic Human Papillomavirus Genotypes in Histologically Confirmed Ear, Nose and Throat (Ent) Cancers in Burkina Faso

Maïmouna Ilboudo et al. Asian Pac J Cancer Prev. .

Abstract

Background: High-risk human papillomavirus (HPV-HR) infections are responsible for 99.99% of cervico-uterine cancers and 50% of carcinomas of the oropharynx.

Objective: To characterize high-risk HPV genotypes (HPV-HR) in histologically confirmed ear, nose and throat (ENT) cancers in Ouagadougou.

Methods: One hundred and twenty-eight archived tissues from the ENT sphere, obtained over the last ten years (2007 to 2017) and histologically diagnosed in anatomy and pathology-cytology laboratories in Ouagadougou were included. These tissues were dewaxed with xylene; HPV DNA extraction was performed and HPV-HR were researched by real-time multiplex PCR.

Results: Among the fourteen HPV-HR genotypes tested for, seven were identified. The prevalence of HPV-HR infection was 15.6%. The most common genotypes were: HPV56 (45%) and HPV33 (20%). Squamous cell carcinomas accounted for 75% of cases, followed by lymphomas for 10%. The age range was between 5 and 80 years.

Conclusion: The results show the involvement of a diversity of HPV-HR genotypes and a high frequency of HPV56 and HPV33 in ENT cancers in Ouagadougou, Burkina Faso. The appropriate HPV vaccination will considerably reduce the number of these cancers.<br />.

Keywords: (high-risk HPV; Burkina Faso; Carcinoma; ENT; Real-Time PCR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of ENT Cancer Cases by Year and Gender from 2007 to 2017
Figure 2
Figure 2
Distribution of ENT Cancer Cases by Age and Gender
Figure 3
Figure 3
Prevalence of HPV-HR Genotypes in Samples

References

    1. Amana B, Foma W, Pegbessou E, et al. Primitive oto-rhino-laryngology and cervico-maxillofacial tumors: epidemiological and histological aspects. Pan Afr Med J. 2016;25:47. - PMC - PubMed
    1. Amana B, Pegbessou E, Boko E, et al. Tumeurs malignes de la parotide: épidémiologie au Togo. Rev Stomatol Chir Maxillofac Chir Orale. 2014;115:15–6. - PubMed
    1. Bambara AT, Millogo MK, Tarcissus BH, et al. Les cancers de la cavité buccale: affection à prédominance féminine à Ouagadougou. Médecine Buccale Chirurgie Buccale. 2015;21:61–6.
    1. Bossard N, Velten M, Remontet L, et al. Survie des patients atteints de cancer en France: principaux résultats de la première étude du réseau des registres français des cancers (Francim) Oncologie. 2007;9:574–80.
    1. Chang F, Syrjanen S, Kellokoski J, et al. Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med. 1991;20:305–17. - PubMed